HK1 and glioblastoma: Because PK-M2 is a rate-limiting glycolytic enzyme, targeting this isoform might inhibit the entire glycolytic pathway, leading to apoptosis, as previously observed by glucose withdrawal in glioblastoma cells in vitro [21].